World News: 07:37 GMT Tuesday 14th November 2017. [Zealand Pharma A/S via Globe Newswire via SPi World News]
- Zealand Pharma announces that all subjects have been enrolled and dosed in a clinical trial with glepaglutide under an investigational new drug application IND for the treatment of short bowel syndrome SBS Following p ositive...
Globe Newswire: 07:37 GMT Tuesday 14th November 2017
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.